Towards Healthcare Research & Consulting
Healthcare Private Equity Market
Updated Date: 13 July 2026   |   Report Code: 6730

Healthcare Private Equity Market Impact of Regulatory Changes, Revenue and Forecast 2035

According to Rohan Patil, who specializes in research related to healthcare services and medical finance, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the healthcare private equity market. The global healthcare private equity market size was estimated at USD 820 million in 2025 and is predicted to increase from USD 911.84 million in 2026 to approximately USD 2370.62 million by 2035, expanding at a CAGR of 11.2% from 2026 to 2035. The analysis based on the survey and research conducted by the research team and Rohal Patil highlights that digital transformation, rising consumer healthcare demands, and AI-based diagnostics are the major trends in the market. The research also examines the competitive strategies of key market players, including New Mountain Capital, General Atlantic, HealthQuest Capital, Nautic Partners, etc.    

Last Updated : 13 July 2026 Category: Healthcare Services Insight Code: 6730 Format: PDF / PPT / Excel

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

Market Dynamics

  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 6: Segmental & Regional Analysis

  • Global XX Market Analysis, By Segment 1
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global XX Market Analysis, By Segment 2
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global XX Market Analysis, By Segment 3
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global XX Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America XX Market Analysis
  • North America XX Market Analysis, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America XX Market Analysis, By Segment 2, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America XX Market Analysis, By Segment 2, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America XX Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U.S. XX Market Analysis
    • U.S. XX Market Analysis, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. XX Market Analysis, By Segment 2, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. XX Market Analysis, By Segment 3, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 7: Competitive Insights

Competitive Analysis

    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Segment 1
      • By Segment 2
      • By Segment 3
    • Strategies of Key Players
    • Insight From the Horse’s Mouth

Company Profiles

    • Company 1
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis

FAQ's

Answer : Healthcare private equity market holds a valuation of USD 911.84 million as of 2026, and will expand to USD 2370.62 million by 2035, achieving a CAGR of 11.2% between 2026 and 2035.

Answer : Recent high-value transactions highlight sustained investor confidence, Novartis AG agreed to transfer its majority stake in Novartis India Limited to ChrysCapital, reflecting strategic portfolio realignment.

Answer : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC. 

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar